Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer.
Cancer Lett. 2019 Nov 1;464:5-14. doi: 10.1016/j.canlet.2019.08.005. Epub 2019 Aug 9.
Cancer Lett. 2019.
PMID: 31404614